0000929638-23-002767.txt : 20231012 0000929638-23-002767.hdr.sgml : 20231012 20231012193845 ACCESSION NUMBER: 0000929638-23-002767 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230929 FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GHALIE RICHARD G CENTRAL INDEX KEY: 0001156208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41827 FILM NUMBER: 231323636 MAIL ADDRESS: STREET 1: C/O FAVRILLE, INC STREET 2: 10445 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 form4.xml X0508 4 2023-09-29 0001262104 MEI Pharma, Inc. MEIP 0001156208 GHALIE RICHARD G C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 true Chief Medical Officer false Stock Option (Right to Buy) 7.01 2023-09-29 4 A 0 30000 0 A 2033-09-29 Common Stock 30000 30000 D One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024. /s/ David M. Urso, as attorney in fact 2023-10-12